Plain-English translation of NCT06388161 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →This research study is looking for immune system antibodies (special proteins your body makes that can attack your brain) in people who have recently started having focal seizures with no clear cause. Researchers will take blood samples and, if needed, spinal fluid samples to test for these antibodies, and they're also creating a scoring tool to help doctors figure out which patients are most likely to have an immune-related seizure disorder.
Many people with new seizures have no obvious cause — like a tumor, infection, or genetic condition — but their seizures might actually be caused by their own immune system attacking their brain. This study aims to figure out how common this problem really is and develop better ways for doctors to identify these patients early, so they can receive the right treatment.
You likely qualify if…
You likely don't qualify if…
You will have blood drawn and possibly undergo a spinal tap (lumbar puncture) to collect cerebrospinal fluid if antibodies are detected in your blood. Doctors will also review your medical history, perform cognitive and mood assessments, and use existing scoring systems to evaluate whether you might have an immune-related seizure disorder. The study involves documentation of your seizure patterns, brain imaging results, and other clinical information to help researchers build a predictive scoring scale.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China